What Is an MDT Review and Why Would a Cannabis Clinic Use It?

The landscape of medical cannabis access in the UK remains complex, sitting at the intersection of evolving legislation, NHS funding limitations, and a growing private market. Within this environment, some cannabis clinics advertise a multidisciplinary team (MDT) review as part of their care offering. But what exactly does an MDT review entail, why do clinics highlight it, and what should patients know before committing to private consultations and prescriptions? This article unpacks these questions while clarifying key regulatory and clinical governance frameworks governing cannabis prescribing in England and beyond.

Understanding the MDT Review: More Than a Buzzword

The term multidisciplinary team or MDT originates from traditional healthcare todaynews.co.uk models where complex patient needs benefit from collaboration among various specialists — such as doctors, nurses, pharmacists, and therapists. For medical cannabis, an MDT review ideally means that more than one clinician with different expertise evaluates a patient's condition and treatment strategy before authorising cannabis-based products.

What Does an MDT Review Involve?

• Multiple healthcare professionals pooling their knowledge to assess a patient’s symptoms, history, and previous treatments.
• Considering alternative options, risks, and benefits of cannabis treatment within the wider clinical context.
• Agreeing on a treatment plan, monitoring requirements, and follow-up arrangements collectively.

In practice, however, the formality and thoroughness of MDT reviews can vary widely in private cannabis clinics. Some clinics may involve two or more qualified prescribers discussing cases, while others rely on one consultant with informal peer input. Transparency about who is involved and their clinical qualifications is crucial for patients seeking confidence in the review process.

Why Would a Cannabis Clinic Use an MDT Review?

There are several reasons clinics emphasise MDT reviews, often framed as a quality signal or a mark of clinical governance rigour:

1. Enhancing patient safety: Multiple clinicians reviewing complex and often off-label use of cannabis medicines can reduce errors and improve personalised dosing.
2. Demonstrating clinical standards: Cannabis prescribing is still rare and experimental in the UK; an MDT approach can distinguish clinics from less rigorous competitors.
3. Meeting regulatory expectations: While the Care Quality Commission (CQC) does not mandate MDT reviews specifically, clinics registered with the CQC in England must uphold robust clinical governance, which an MDT can support.
4. Supporting remote care models: The rise of video consultations and remote prescribing—both legal and CQC-declared services—can be integrated into MDT workflows for efficient patient access.

MDT Reviews and Remote Services: A Modern Clinic Must-Have?

The pandemic accelerated healthcare digitalisation, and cannabis clinics have adopted video consultations and remote prescribing accordingly. Remote prescribing lets registered specialists issue cannabis prescriptions without in-person visits, provided they follow stringent protocols and declare these services to the CQC in England. An MDT review conducted virtually or through asynchronous case discussions can maintain clinical governance standards while facilitating convenience.

Nonetheless, patients should be cautious since not all clinics clearly disclose the exact process, the team members involved, or the full costs entailed.

Separating Legality From Real-World Access

Medical cannabis was legalised for prescription in the the UK in 2018, but actual access remains limited within the NHS. Most patients do not receive cannabis-based medicinal products (CBMPs) via NHS prescriptions because:

• There is insufficient high-quality clinical trial evidence approved by NICE (National Institute for Health and Care Excellence) to support widespread NHS funding.
• NHS clinicians are generally reluctant or lack expertise to prescribe cannabis given current guidelines.
• NHS funding pressures prioritise medicines with strong evidence and cost-effectiveness.

This gap has created a sizeable private market where patients pay out-of-pocket for consultations and prescriptions from cannabis clinics. Here, the promise of MDT reviews can be a differentiator, but the private model comes with uncertainties about costs, follow-up care, and the robustness of clinical governance.. (sorry, got distracted)

Checklist: What Patients Should Ask About MDT Reviews at Cannabis Clinics

• Who exactly is on the multidisciplinary team? Check professional credentials, especially that prescribing doctors are on the GMC Specialist Register.
• Is the MDT review process documented? Ask if team discussions and decisions are recorded and shared with you.
• How do video consultations and remote prescribing work? Confirm session lengths, technical platforms, and security/privacy measures.
• What are the full, transparent costs? Look for clear pricing on consultations, follow-ups, prescription fees, and medication costs.
• What ongoing clinical governance safeguards are in place? Including mechanisms for adverse event monitoring and quality audits.

Who Can Prescribe Medical Cannabis in the UK?

This reminds me of something that happened learned this lesson the hard way.. Prescribing medical cannabis is highly regulated. In England, doctors must be on the General Medical Council (GMC) Specialist Register to prescribe cannabis-based products for medicinal use. General practitioners (GPs) cannot initiate cannabis treatment, but specialists in relevant fields—such as pain medicine, neurology, or psychiatry—can.

This rule aims to ensure that prescribing occurs within a specialist clinical context suitable for complex conditions that might benefit from cannabis. Cannabis clinics touting MDT processes often highlight consultant specialists involved in the team, providing reassurance about clinical expertise.

Regulation and CQC Oversight in England

Private clinics providing cannabis prescribing services must register with the Care Quality Commission (CQC) in England. The CQC oversees the safety, effectiveness, and patient experience of these services.

Aspect Requirement Implication for Cannabis Clinics Registration Mandatory for all private healthcare providers Ensures minimum quality and safety standards Remote Prescribing Declaration Must declare use of remote consultations and remote prescriptions Enhances transparency and regulatory oversight Clinical Governance Clinics must have arrangements for clinical audit, quality assurance, and patient feedback Supports continuous care improvement and safety Staff Qualifications Clinicians must be properly qualified and registered with GMC Protects patient safety and prescribing appropriateness

While the CQC provides a regulatory baseline, it does not prescribe exactly how MDT reviews should be structured or mandated. Therefore, the presence of a formal MDT review remains a voluntary quality enhancement rather than a regulatory requirement.

A Common Mistake: Opaque Pricing Without Breakdown

In private cannabis clinics, one of the biggest consumer pitfalls is lack of transparent pricing. Many clinics advertise MDT reviews and ongoing care but fail to clearly state:

• Consultation fees for initial and follow-up visits
• Cost of remote consultations versus in-person visits
• Prescription costs including pharmacist fees
• Price variability based on condition or medication strength
• Whether video consultation fees include prescription or are separate

This opaque approach leads to unexpected expenses and undermines trust. High-quality clinics should provide detailed price lists upfront, ideally on their websites, so patients can make informed decisions.

Summary: What to Look For in an MDT Review at a Cannabis Clinic

Criterion What It Means Why It Matters Multidisciplinary Team Composition Qualified doctors, pharmacists, and allied health professionals collaborating Improves clinical decision-making and safety Transparent Clinical Governance Documented protocols, audit, and monitoring systems Ensures adherence to standards and patient protection Clear Declaration of Remote Prescribing Services registered with CQC and declared officially Compliance with regulation and patient assurance Transparent Pricing Detailed fees for consultation, ongoing care, and prescriptions Supports informed consent and prevents billing surprises Specialist Prescribing Clinicians Doctors on the GMC Specialist Register with relevant expertise License and competence for cannabis prescribing

Final Thoughts

An MDT review can be a valuable quality signal when navigating the private medical cannabis marketplace. It suggests a clinic’s commitment to thorough, collaborative clinical governance in a field where evidence is still emerging, and access via the NHS is limited. However, patients should remember that legality does not guarantee easy access, and private consultations can be costly.. Pretty simple.

Choosing a cannabis clinic requires careful research: verify the composition of the MDT, check regulatory registration and declarations, confirm who is authorised to prescribe, and demand clear, upfront pricing. By doing so, patients can make safer, better-informed choices amid the rapidly evolving landscape of medical cannabis care in the UK.